Visioneering Technologies, Inc. (VTI.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.67 Million AUD | 79.3% |
| 2022 | 7.28 Million USD | 1.83% |
| 2021 | 7.15 Million AUD | 40.14% |
| 2020 | 5.1 Million AUD | -10.78% |
| 2019 | 5.72 Million AUD | 73.71% |
| 2018 | 3.29 Million AUD | 214.01% |
| 2017 | 1.04 Million AUD | 261.03% |
| 2016 | 290.55 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 3.5 Million USD | 0.37% |
| 2023 Q3 | 3.11 Million USD | -11.3% |
| 2023 FY | 13.06 Million AUD | 79.3% |
| 2023 Q4 | 2.93 Million USD | -5.68% |
| 2023 Q1 | 3.49 Million USD | 33.39% |
| 2022 Q3 | 2.78 Million USD | 3.51% |
| 2022 Q4 | 2.61 Million USD | -6.05% |
| 2022 FY | 7.28 Million USD | 1.83% |
| 2022 Q2 | 2.69 Million USD | 0.0% |
| 2021 FY | 7.15 Million AUD | 40.14% |
| 2020 FY | 5.1 Million AUD | -10.78% |
| 2019 Q2 | 2.04 Million AUD | 0.0% |
| 2019 Q1 | 2.04 Million AUD | 0.0% |
| 2019 FY | 5.72 Million AUD | 73.71% |
| 2018 Q1 | 1.16 Million AUD | 0.0% |
| 2018 FY | 3.29 Million AUD | 214.01% |
| 2018 Q4 | 2.04 Million AUD | 0.0% |
| 2018 Q2 | 1.16 Million AUD | 0.0% |
| 2017 Q1 | 336.21 Thousand AUD | 0.0% |
| 2017 Q2 | 336.21 Thousand AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | 1.04 Million AUD | 261.03% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q4 | 336.21 Thousand AUD | 0.0% |
| 2016 FY | 290.55 Thousand AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -130.938% |
| Adherium Limited | 840.98 Thousand AUD | -930.938% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 86.316% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -112.16% |
| Anteris Technologies Ltd | 4.11 Million AUD | -110.893% |
| Control Bionics Limited | 5.12 Million AUD | -69.108% |
| CardieX Limited | 10.9 Million AUD | 20.5% |
| Compumedics Limited | 49.71 Million AUD | 82.562% |
| Cochlear Limited | 2.25 Billion AUD | 99.616% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 44.853% |
| Cyclopharm Limited | 27.13 Million AUD | 68.054% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 22.722% |
| Nova Eye Medical Limited | 23.32 Million AUD | 62.83% |
| HeraMED Limited | 402.89 Thousand AUD | -2051.915% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -1308.455% |
| ImpediMed Limited | 10.31 Million AUD | 15.98% |
| InhaleRx Limited | 1.2 Million AUD | -620.072% |
| LBT Innovations Limited | 1.25 Million AUD | -590.287% |
| Micro-X Limited | 15.22 Million AUD | 43.043% |
| Neurotech International Limited | 1963.00 AUD | -441570.912% |
| OncoSil Medical Limited | 1.56 Million AUD | -453.858% |
| PolyNovo Limited | 103.19 Million AUD | 91.598% |
| Respiri Limited | 456.91 Thousand AUD | -1797.512% |
| SomnoMed Limited | 91.65 Million AUD | 90.54% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -30.713% |
| Uscom Limited | 3.72 Million AUD | -132.636% |